Analyses / ARM
Record Q1 revenue + AI tailwinds offset by guidance disappointment; extreme valuation taxes near-term upside.
A free account reveals ARM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Record Q1 revenue, 22.5% YoY growth. AI chip demand structural tailwind. 97.5% gross margin; licensing model provides recurring, high-margin revenue. 5Y EPS CAGR 17.5%. Balance sheet fortress (current ratio 6.0x). Industry secular growth as compute architecture shifts.
▼ Bear Case
P/E 288x / Forward P/E 288x — extreme. P/S 53x vs semiconductor peers at 5–15x. Stock down 50% from 52-week high ($452.70); Q1 guidance disappointed despite beat. P/FCF 274x. Insider selling 66 sells vs 49 buys. Negative sentiment post-earnings. High beta (4.01) amplifies downside in drawdowns.
Valuation
OVERVALUED on legacy multiples; fairly-valued only if 20%+ annual EPS growth persists — score 28/100
P/E 288x, P/S 53x, and P/FCF 274x are extreme even for high-growth semiconductor licensors. Peers typically trade 5–12x P/S and 25–50x P/E. ARM justifies premium only if: (1) AI demand validates 22–25% revenue CAGR for 5+ years, (2) operating leverage drives 25%+ net margin (vs. current 18.4%), and (3) multiple stays elevated. Any disappointment in these vectors causes sharp retracement.
Technical Levels
Support · $190.00 (Stop Loss / Key Support) · $210.00 (Recent Swing Low / Mid-Term Support) · $222.00 (Today's Low / Intraday Support)
Resistance · $243.00 (Today's High / Intraday Resistance) · $260.00 (Near-Term Resistance) · $330.00 (Intermediate Resistance (50% of 52W range)) · $452.00 (52-Week High / Major Resistance)
RSI: Not disclosed in provided data
Financial Health
Score 88/100. Balance sheet is fortress-like: liquidity ratios 5.6–6.0x indicate zero solvency risk. No dividend and strong cash generation imply flexibility. Debt-to-equity unavailable; assume low leverage given margins and balance sheet ratios. Financial health is not a risk factor.
Risk Flags
See ARM's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock ARM free →Recent News
- Arm Holdings Tops First-Quarter Forecasts, but Shares Extend DeclineYahoo
- ARM Holdings PLC (ARM) (Q1 2027) Earnings Call Highlights: Record Revenue and AI Growth Amid ...Yahoo
- ARM Holdings (NASDAQ:ARM) Fiscal Q1 Results Beat Estimates but Guidance Disappoints, Shares Drop 6%ChartMill
- Arm Holdings plc (ARM) Q1 2027 Earnings Call TranscriptSeekingAlpha
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full ARM analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
ARM FAQ
Is ARM a buy right now?
Arm Holdings PLC's current read is a Growth / Momentum with Valuation Concern setup with 55 confidence over a 6-12 months horizon. Valuation: OVERVALUED on legacy multiples; fairly-valued only if 20%+ annual EPS growth persists. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is ARM overvalued?
OVERVALUED on legacy multiples; fairly-valued only if 20%+ annual EPS growth persists (valuation score 28/100). P/E 288x, P/S 53x, and P/FCF 274x are extreme even for high-growth semiconductor licensors. Peers typically trade 5–12x P/S and 25–50x P/E. ARM justifies premium only if: (1) AI demand validates 22–25% revenue CAGR for 5+ years, (2) operating leverage drives 25%+ net margin (vs. current 18.4%), and (3) multiple stays elevated. Any disappointment in these vectors causes sharp retracement.
What are the risks of buying ARM?
P/E 288x / Forward P/E 288x — extreme. P/S 53x vs semiconductor peers at 5–15x. Stock down 50% from 52-week high ($452.70); Q1 guidance disappointed despite beat. P/FCF 274x. Insider selling 66 sells vs 49 buys. Negative sentiment post-earnings. High beta (4.01) amplifies downside in drawdowns.